Home › Funds › ArrowMark Colorado Holdings LLC › TNDM

ArrowMark Colorado Holdings LLC position in TNDM

TANDEM DIABETES · Health Care

ArrowMark Colorado Holdings LLC reported holding 1,299,586 shares of TNDM (TANDEM DIABETES) in its Q2 2026 13F filing — a position valued at US$19.6M, representing 0.82% of its reported portfolio and ranking #22 among its reported holdings. ArrowMark Colorado Holdings LLC has disclosed TNDM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.30M sh
Reported value held$19.61M
Portfolio Weight0.82%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ArrowMark Colorado Holdings LLC's TNDM position evolved

ArrowMark Colorado Holdings LLC first disclosed a stake in TNDM in Q3 2023 at 1,631,544 shares (US$33.9M). The position peaked in Q1 2024 at 2,934,179 shares, worth US$103.9M. Across 12 filings, ArrowMark Colorado Holdings LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,299,586 shares valued at US$19.6M — a reduction of -1,804,023 shares quarter over quarter.. Notable position changes include a 80% increase in Q4 2023 (shares rose 20% over the following quarter), a 37% increase in Q3 2025 (shares rose 81% over the following quarter), a 58% trim in Q2 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.63M $33.89M New
Q4 2023 2.94M $86.82M Add
Q1 2024 2.93M $103.90M Hold
Q2 2024 2.50M $100.92M Reduce
Q3 2024 2.39M $101.22M Reduce
Q4 2024 2.72M $98.11M Add
Q1 2025 2.72M $52.04M Hold
Q2 2025 2.70M $50.32M Reduce
Q3 2025 3.69M $44.81M Add
Q4 2025 2.89M $63.52M Reduce
Q1 2026 3.10M $59.50M Add
Q2 2026 1.30M $19.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNDM and 13F data

TNDM (TANDEM DIABETES) is a Health Care company. 17 other funds we track also report a position in TNDM — the largest reported positions include Sessa Capital IM, L.P. (US$77.0M), First Light Asset Management, LLC (US$51.1M), Paradice Investment Management LLC (US$32.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNDM

All TNDM fund holders →

FAQ

How long has ArrowMark Colorado Holdings LLC held TNDM?

ArrowMark Colorado Holdings LLC has disclosed TNDM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ArrowMark Colorado Holdings LLC's current position in TNDM?

As of Q2 2026, ArrowMark Colorado Holdings LLC holds 1.30M shares of TNDM (TANDEM DIABETES), valued at $19.61M, representing 0.82% of its reported portfolio and ranking #22.

Has ArrowMark Colorado Holdings LLC been buying or selling TNDM?

In the latest 13F filing (Q2 2026), ArrowMark Colorado Holdings LLC reduced its position in TNDM. The position peaked in Q1 2024 at 2.93M shares.

Which other funds hold TNDM?

Other major institutional holders of TNDM include Sessa Capital IM, L.P., First Light Asset Management, LLC, Paradice Investment Management LLC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.